Back to Tom Steyer
Tom Steyer → BSX via FARALLON CAPITAL MANAGEMENT, L.L.C.
Tom Steyer BSX Position History
Boston Scientific Corporation • Healthcare
Quarters held
15
Latest value
$449M
Q2 2026
Peak value
$709.4M
First seen
Q2 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $449M | 10.52M | — | — |
| Q1 2026 | $468.8M | 7.47M | — | — |
| Q4 2025 | $709.4M | 7.44M | — | — |
| Q3 2025 | $463.4M | 4.75M | — | — |
| Q3 2025 | $463.4M | 4.75M | — | — |
| Q2 2025 | $427.6M | 3.98M | — | — |
| Q1 2025 | $379.6M | 3.76M | — | — |
| Q4 2024 | $448.7M | 5.02M | — | — |
| Q3 2024 | $454.7M | 5.43M | — | — |
| Q2 2024 | $316.4M | 4.11M | — | — |
| Q1 2024 | $314.8M | 4.60M | — | — |
| Q1 2024 | $314.8M | 4.60M | — | — |
| Q4 2023 | $336.5M | 5.82M | — | — |
| Q3 2023 | $266.1M | 5.04M | — | — |
| Q2 2023 | $272.9M | 5.05M | — | — |